InvestorsHub Logo
Followers 14
Posts 2874
Boards Moderated 0
Alias Born 12/23/2014

Re: jfk post# 1001

Tuesday, 07/27/2021 9:25:59 AM

Tuesday, July 27, 2021 9:25:59 AM

Post# of 1155
I see the DYAI C1, platform as having lower upfront costs, easily scalable, and faster initial turn around time. These advantages make it ideal for new and/or mutated virus. In drug development quick development can save lives and limit spread.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News